Funding Received
$5.3 Million in 1 Round from 4 Investors
Most Recent Funding
$5.3 Million Series A on January 7, 2013
Headquarters:
Bellshill
Description:
Lamellar Biomedical develops novel healthcare products based on the mimicry or modification of the lamellar body secretory system.
Categories:
Biotechnology
Website:
http://lamellar.com

Detailed Description

Update

Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.

Current Team (1)

Update

Funding Rounds (1) - $5.3M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Caledonian House

    Phoenix Crescent

    Bellshill, ML4 3NJ

    GBR